J
John P. Boehmer
Researcher at Penn State Milton S. Hershey Medical Center
Publications - 162
Citations - 16317
John P. Boehmer is an academic researcher from Penn State Milton S. Hershey Medical Center. The author has contributed to research in topics: Heart failure & Cardiac resynchronization therapy. The author has an hindex of 42, co-authored 145 publications receiving 15087 citations. Previous affiliations of John P. Boehmer include University of Alabama at Birmingham & Rush University Medical Center.
Papers
More filters
Journal ArticleDOI
Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study).
Michael Phillips,John P. Boehmer,Renee N. Cataneo,Taseer Cheema,Howard J. Eisen,John T. Fallon,Peter E. Fisher,Alan Gass,Joel Greenberg,Jon A. Kobashigawa,Donna Mancini,Barry Rayburn,Mark J. Zucker +12 more
TL;DR: A breath test for markers of oxidative stress was more sensitive and less specific for Grade 3 heart transplant rejection than a biopsy reading by a site pathologist, but the negative predictive values of the 2 tests were similar.
Journal ArticleDOI
Does total implantability reduce infection with the use of a left ventricular assist device? The LionHeart experience in Europe.
Walter E. Pae,John M. Connell,Amos Adelowo,John P. Boehmer,Reiner Körfer,Aly El-Banayosy,Roland Hetzer,Mario Viganò,Alain Pavie +8 more
TL;DR: The patients in the European LionHeart Clinical Utility Baseline Study (CUBS) trial had less sepsis and less overall DRI compared with the REMATCH LVAD group, suggesting the fully implanted device may cause less infection than PC devices during destination therapy (DT).
Journal ArticleDOI
A Multicenter, Prospective, Randomized, Double-Blind Trial of Basiliximab in Heart Transplantation
Mandeep R. Mehra,Mark J. Zucker,Lynne E. Wagoner,Robert E. Michler,John P. Boehmer,John M. Kovarik,Arthur Vasquez +6 more
TL;DR: It is shown that basiliximab appears to be tolerated with a similar safety profile to placebo in adult de novo heart transplant recipients and larger scale clinical trials are feasible and warranted.
Journal ArticleDOI
Impact of cardiac resynchronization therapy on exercise performance, functional capacity, and quality of life in systolic heart failure with QRS prolongation: COMPANION trial sub-study.
Teresa De Marco,Eugene E. Wolfel,Arthur M. Feldman,Brian D. Lowes,Michael B. Higginbotham,Jalal K. Ghali,Lynne E. Wagoner,Philip C. Kirlin,Jerry D. Kennett,Satish Goel,Leslie A. Saxon,John P. Boehmer,David E. Mann,Elizabeth Galle,Fred Ecklund,Patrick Yong,Michael R. Bristow +16 more
TL;DR: CRT patients with moderate to advanced symptoms of systolic heart failure and prolonged QRS intervals benefit from the addition of CRT to OPT in terms of exercise capacity, functional status, and QOL.
Journal ArticleDOI
Demographic features and prevalence of idiopathic myocarditis in patients undergoing endomyocardial biopsy.
Ahvie Herskowitz,Stephen Campbell,J.W. Deckers,Edward K. Kasper,John P. Boehmer,Djavid Hadian,David A. Neumann,Kenneth L. Baughman +7 more
TL;DR: From January 1985 through December 1990, 534 patients underwent endomyocardial biopsy at Johns Hopkins Hospital for suspected myocarditis, with a peak in the proportion of patients found to have activeMyocarditis on biopsy occurred in 1986.